Related Experiment Videos
Prognostic scoring systems in differentiated thyroid carcinoma: which is the best?
G Kingma1, H A van den Bergen, J E de Vries
1Department of Surgery, Sophia Hospital, Zwolle, The Netherlands.
The Netherlands Journal of Surgery
|June 1, 1991
Summary
The AGES index is the most effective tool for predicting survival in differentiated thyroid cancer, outperforming the TNM system and EORTC score. This scoring system offers the best prognostic bisection for patients.
Area of Science:
- Oncology
- Medical Statistics
Background:
- Differentiated thyroid carcinoma (DTC) prognosis assessment is crucial for patient management.
- Existing prognostic scoring systems include the TNM system, EORTC score, and AGES index.
- Evaluating these systems in a real-world clinical setting is necessary.
Purpose of the Study:
- To compare the clinical utility of the TNM system, EORTC score, and AGES index for predicting outcomes in differentiated thyroid carcinoma.
- To determine the most effective prognostic scoring system for use in a medium-sized teaching hospital.
Main Methods:
- Retrospective analysis of 21 patients with differentiated thyroid carcinoma (papillary, mixed, follicular).
- Median follow-up of over seven years (10-194 months).
- Evaluation of the discriminatory power of TNM, EORTC, and AGES scoring systems.
Main Results:
- The TNM system showed poor discrimination between good and lethal prognoses.
- The EORTC score provided a good prediction of survival and is easy to calculate.
- The AGES index demonstrated the best discrimination, particularly for papillary tumors, accurately stratifying patients into good and poor prognostic groups.
Conclusions:
- The AGES index is the most valuable prognostic scoring system for differentiated thyroid carcinoma.
- The TNM system has limited utility for these tumors.
- The EORTC score offers a practical alternative for survival prediction.